Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Should breast cancer patients be the focus of anti-smoking campaigns in transitional countries? (CROSBI ID 705252)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija

Golčić, Marin ; Tomaš, Ilijan ; Stevanović, Aleksandra ; Golčić, Goran ; Dobrila-Dintinjana , Renata ; Cink Škalic, Mirjana ; Šambić Penc , Mirela ; Gović-Golčić, Lidija ; Baretić Marinac, Martina ; Belac Lovasić , Ingrid Should breast cancer patients be the focus of anti-smoking campaigns in transitional countries? // Supportive care in cancer. 2019. str. 1-302 doi: 10.1007/s00520-019-04813-1

Podaci o odgovornosti

Golčić, Marin ; Tomaš, Ilijan ; Stevanović, Aleksandra ; Golčić, Goran ; Dobrila-Dintinjana , Renata ; Cink Škalic, Mirjana ; Šambić Penc , Mirela ; Gović-Golčić, Lidija ; Baretić Marinac, Martina ; Belac Lovasić , Ingrid

engleski

Should breast cancer patients be the focus of anti-smoking campaigns in transitional countries?

Introduction Studies have shown that breast cancer patients who smoke during cancer treatment, along with a higher symptom burden, exhibit a dramatically higher risk of death (HR 3.52). Majority of studies report that only 8-14% breast cancer survivors smoke, although recent research shows low smoking cessation in breast cancer patients in Western population after cancer diagnosis. Currently, although around 30% of females in Croatia are active smokers, no analysis regarding smoking cessation have been done. Methods The study was cross-sectional research in two clinical hospital centers in Croatia and involved 168 breast cancer patients undergoing active treatment, using a questionnaire. Results Breast cancer patients are relatively young (57.6±11.31 years) and rarely metastatic (22%). Only around a quarter of breast cancer patients smoked at the time of cancer diagnosis. However, 96% of breast cancer patients continue to smoke after a cancer diagnosis, although the percentage of patients who smoke over ten cigarettes a day dropped from 70% to 36%. However, these numbers are higher compared to other patients and are much higher than previously reported for the Western population. Conclusions Although breast cancer patients are expected to exhibit relatively long survival compared to other cancers, they are one of the patient groups least likely to engage in smoking cessation during the treatment, possibly due to low perceived risk. With new research emphasizing the dangers of smoking during cancer treatment, breast cancer patients should be one of the focus groups, especially in transitional countries with a high number of female smokers.

breast cancer ; smoking

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

1-302.

2019.

nije evidentirano

objavljeno

10.1007/s00520-019-04813-1

Podaci o matičnoj publikaciji

Supportive care in cancer

Springer Science+Business Media

0941-4355

Podaci o skupu

2019 MASCC/ISOO Annual Meeting

poster

21.06.2019-23.06.2019

San Francisco (CA), Sjedinjene Američke Države

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost